iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding iSpecimen Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 8 | 9 | +1 |
| Shares | 60.1K | 67.4K | +7.37K (+12.3%) |
| Value | $63.7K | $66.1K | +$2.41K (+3.8%) |
New holders (2)
Institutions that held iSpecimen Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 19,464 | $19.1K | 0.00% |
| XTX Topco Ltd | 10,084 | $9.88K | 0.00% |
Sold out (1)
Institutions that held iSpecimen Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Bridgeway Capital Management, LLC | 21,800 | $23.1K |